Capricor Therapeutics, Inc. (CAPR) earnings per share (EPS)

Earnings per share · fiscal 2025
-$2.26

Capricor Therapeutics, Inc. (CAPR) reported diluted earnings per share of -$2.26 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.15. Figures as of 17 Nov 2026, 19:00 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$2.26
Highest on record
$0.90fiscal 2017
Lowest on record
-$10.10fiscal 2016
Fiscal years on record
92016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Capricor Therapeutics, Inc. earnings per share (EPS), in more detail

Across the 9 fiscal years on record (2016–2025), the highest was $0.90 in fiscal 2017 and the lowest -$10.10 in fiscal 2016.

History · 9 fiscal years

Earnings per share by fiscal year

Capricor Therapeutics, Inc. earnings per share (EPS), year by year

Capricor Therapeutics, Inc. (CAPR) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$2.26—
2024-$1.15—
2023-$0.83—
2022-$1.18—
2021-$0.87—
2020-$0.88—
2018-$0.52 157.8% down
2017$0.90—
2016-$10.10—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on CAPR

Capricor Therapeutics, Inc., figure by figure

Capricor Therapeutics, Inc. (CAPR) overview: price, valuation and scorecard

Capricor Therapeutics, Inc. earnings per share (EPS): questions and answers

What is Capricor Therapeutics, Inc.'s diluted earnings per share?

Capricor Therapeutics, Inc. (CAPR) reported diluted earnings per share of -$2.26 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.15.

What are the highest and lowest diluted earnings per share figures on record for Capricor Therapeutics, Inc.?

Across the 9 fiscal years on record (2016–2025), the highest was $0.90 in fiscal 2017 and the lowest -$10.10 in fiscal 2016.

How is Capricor Therapeutics, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Capricor Therapeutics, Inc. (CAPR) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/CAPR/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.